Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
Clinical trial NCT03011008 · UNKNOWN
Trial details
- NCT number
- NCT03011008
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.